HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Marina Tintelnot-Blomley Selected Research

2- (4- chlorophenyl)- 2,5- dihydropyrazolo(4,3- c)quinoline- 3(3H)- one

3/2011Exploring subtype selectivity and metabolic stability of a novel series of ligands for the benzodiazepine binding site of the GABAA receptor.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Marina Tintelnot-Blomley Research Topics

Disease

5Alzheimer Disease (Alzheimer's Disease)
10/2021 - 08/2005
2Dementia (Dementias)
11/2018 - 09/2015
1Asymptomatic Diseases
11/2018
1Amyloid Plaque
11/2018
1Neuroinflammatory Diseases
09/2015
1Sleep Initiation and Maintenance Disorders (Insomnia)
03/2011
1Neurodegenerative Diseases (Neurodegenerative Disease)
08/2003

Drug/Important Bio-Agent (IBA)

2UmibecestatIBA
10/2021 - 11/2018
2Amyloid (Amyloid Fibrils)IBA
11/2018 - 09/2015
2EnzymesIBA
08/2005 - 08/2005
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
10/2021
1Proteins (Proteins, Gene)FDA Link
11/2018
1NB-360IBA
09/2015
1GABA-A Receptors (GABA(A) Receptor)IBA
03/2011
1Oxygen (Dioxygen)IBA
03/2011
12- (4- chlorophenyl)- 2,5- dihydropyrazolo(4,3- c)quinoline- 3(3H)- oneIBA
03/2011
1pyrazoloneIBA
03/2011
1Pyrrolidinones (Pyrrolidones)IBA
08/2005
1PeptidomimeticsIBA
08/2005
1Cyclophilins (Cyclophilin)IBA
08/2003

Therapy/Procedure

1Therapeutics
11/2018